Visionary Wealth Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
– Sell
-401
Closed -$248K – 561
2024
Q3
$248K Sell
401
-22
-5% -$13K 0.02% 480
2024
Q2
$234K Sell
423
-17
-4% -$9.74K 0.02% 465
2024
Q1
$256K Hold
440
– – 0.02% 426
2023
Q4
$234K Sell
440
-56
-11% -$27.1K 0.02% 437
2023
Q3
$251K Sell
496
-15
-3% -$7.99K 0.02% 396
2023
Q2
$267K Hold
511
– – 0.02% 386
2023
Q1
$295K Sell
511
-20
-4% -$11.3K 0.03% 356
2022
Q4
$292K Sell
531
-10
-2% -$5.3K 0.03% 327
2022
Q3
$274K Buy
541
+21
+4% +$11.8K 0.03% 315
2022
Q2
$283K Sell
520
-1
-0.2% -$550 0.03% 333
2022
Q1
$308K Sell
521
-11
-2% -$6.32K 0.02% 321
2021
Q4
$355K Buy
532
+10
+2% +$6.24K 0.03% 269
2021
Q3
$298K Sell
522
-30
-5% -$16.5K 0.03% 249
2021
Q2
$278K Sell
552
-17
-3% -$8.02K 0.03% 278
2021
Q1
$260K Buy
569
+4
+0.7% +$1.91K 0.03% 276
2020
Q4
$263K Sell
565
-10
-2% -$4.69K 0.03% 250
2020
Q3
$254K Buy
+575
New +$238K 0.04% 212

Other funds holding TMO

Visionary Wealth Advisors's TMO Position: Q4 2024 in Review

Visionary Wealth Advisors sold out of Thermo Fisher Scientific (TMO) in Q4 2024, closing a stake of 401 shares — an estimated $248K sold.

Visionary Wealth Advisors first reported a position in TMO in Q3 2020 and held it in 17 quarters. The position peaked at $355K in Q4 2021. 2,624 funds tracked by Wall St. Rank hold TMO as of Q4 2024.

  • Visionary Wealth Advisors reported no remaining Thermo Fisher Scientific position as of Q4 2024 after selling out during the quarter.
  • Visionary Wealth Advisors sold 401 Thermo Fisher Scientific shares in Q4 2024, an estimated $248K.
  • Visionary Wealth Advisors first reported a position in Thermo Fisher Scientific in Q3 2020 and held it in 17 quarters.
  • Visionary Wealth Advisors's Thermo Fisher Scientific position peaked at $355K in Q4 2021.
  • 2,624 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2024.

Based on Visionary Wealth Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.